Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Oncological Patients With Endocrine Complications After Immunotherapy With Checkpoint Inhibitors Present Longer Progression-Free and Overall Survival — Stavroula Α. Paschou (2022) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Oncological Patients With Endocrine Complications After Immunotherapy With Checkpoint Inhibitors Present Longer Progression-Free and Overall Survival
Shared by
Meletios A Dimopoulos
Oncological Patients With Endocrine Complications After Immunotherapy With Checkpoint Inhibitors Present Longer Progression-Free and Overall Survival
Article
2022
en
Authors
+6 more
SP
Stavroula Α. Paschou
ML
Michalis Liontos
EE
Evangelos Eleftherakis-Papaiakovou
Abstract
1 min read
ICI endocrinopathies may be a positive predictor of immunotherapy response.
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2022
Oncological patients with endocrine complications after immunotherapy with checkpoint inhibitors present longer progression free and overall survival
Stavroula Α. Paschou
,
Michalis Liontos
,
Evangelos Eleftherakis-Papaiakovou
,
Katerina Stefanaki
,
Christos Markellos
,
Konstantinos Koutsoukos
,
Flora Zagouri
,
Θεοδώρα Ψαλτοπούλου
,
Meletios A Dimopoulos
Article
2021
Oncological Patients with Endocrine Complications after Immunotherapy with Checkpoint Inhibitors Present Longer Progression Free and Overall Survival
Stavroula Α. Paschou
,
Michalis Liontos
,
Evangelos Eleftherakis-Papaiakovou
,
Katerina Stefanaki
,
Christos Markellos
,
Konstantinos Koutsoukos
,
Flora Zagouri
,
Θεοδώρα Ψαλτοπούλου
,
Meletios A Dimopoulos
Article
2021
How we treat endocrine complications of immune checkpoint inhibitors
Stavroula Α. Paschou
,
Katerina Stefanaki
,
Θεοδώρα Ψαλτοπούλου
,
Michalis Liontos
,
Konstantinos Koutsoukos
,
Flora Zagouri
,
Ιrene Lambrinoudaki
,
Meletios A Dimopoulos
Article
2021
Nephrotoxicity in patients with cancer treated with immune checkpoint inhibitors.
Evangelos Eleutherakis Papaiakovou
,
Efstathios Kastritis
,
Flora Zagouri
,
Dimitra Grapsa
,
Ioannis Ntanassis-Stathopoulos
,
Dimitra Stefanou
,
George Evangelou
,
Ilias Kotteas
,
Meletios A Dimopoulos
,
Konstantinos Syrigos
Article
2022
How Compatible Are Immune Checkpoint Inhibitors and Thermal Ablation for Liver Metastases?
Yasunori Minami
,
Haruyuki Takaki
,
Koichiro Yamakado
,
Masatoshi Kudo
Discussion(0)
No comments yet. Be the first to comment.